Your Account
Sort
Categories
- #EMSPVirtual2021
- Associate members
- Document
- EMSP Events
- EMSP Events|EMSP News
- EMSP News
- EMSP News|From Europe
- EMSP News|From Europe|Stakeholder Events
- EMSP News|MS Research
- EMSP News|Press Releases
- EMSP News|Young People with MS
- From Europe
- From Europe|Member News
- From Europe|Stakeholder Events
- From Europe|Young People with MS
- Full members
- Full members|Member News
- Member News
- Member News|Young People with MS
- MS Research
- News – EMSP
- News2
- Press Releases
- Stakeholder Events
- Uncategorized
- Young People with MS
EU and US enhance collaboration on patient involvement in medicines development
The European Medicines Agency (EMA) and the United States Food and Drug Administration (FDA) have agreed to set up a forum…
EU and US enhance collaboration on patient involvement in medicines development
The European Medicines Agency (EMA) and the United States Food and Drug Administration (FDA) have agreed to set up a forum…
RiMS: Course on rehabilitation in multiple sclerosis
EMSP’s partners from Rehabilitation in MS (RiMS) are endorsing a residential course on rehabilitation in multiple sclerosis (MS) which will…
IMPRESS study: Focus on people with MS and their carers
The London School of Economics (LSE) is currently leading a study – IMPRESS – which explores the social economic costs, quality of life and…
Ireland: National-level launch of EMSP’s Employment Toolkit
MS Ireland are set to launch an adapted version of EMSP’s Employment Toolkit for the benefit of those living with multiple…
Ireland: National-level launch of EMSP’s Employment Toolkit
MS Ireland are set to launch an adapted version of EMSP’s Employment Toolkit for the benefit of those living with multiple…
